Patricia Martin

Patricia A. Martin currently serves as Director at Indiana University Foundation, Inc., Christian Theological Seminary, Inc., Regenstrief Institute, Inc., Indiana University Melvin & Bren Simon Cancer Center, and P2k Dynamics, Inc. She is an Independent Director at AN2 Therapeutics, Inc. since 2021 and at Cypherpunk Technologies, Inc. since 2023.
She is a Member of the Healthcare Businesswomens Association and a Board Member at CareSource since 2015.
She is also the Managing Partner at Bc Initiative, Inc. since 2019.
Formerly, Ms. Martin was President and CEO of BioCrossroads from 2019 to 2023.
She was Director at Flame Biosciences LLC from 2020 to 2021, and Director at Indiana Biosciences Research Institute and Indiana Health Information Exchange, Inc. from 2019 to 2023.
From 1991 to 2017, she was Vice President-Global Diversity at Eli Lilly & Co. She was President-Operations at Eli Lilly & Co. Ltd. She was a Member of The National Alliance For Hispanic Health.
From 2010 to 2017, she was Chief Operating Officer at Lilly Diabetes.
Ms. Martin completed undergraduate studies at Indiana University and Kelley School of Business, graduating in 1982.
She earned an MBA from Harvard Business School in 1991.